Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-12, Vol.30, p.xi35-xi36 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | xi36 |
|---|---|
| container_issue | |
| container_start_page | xi35 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Rischin, D. Khushalani, N.I. Schmults, C.D. Guminski, A. Chang, A.L.S. Lewis, K.D. Lim, A.M. Hernandez-Aya, L. Hughes, B.G.M. Schadendorf, D. Hauschild, A. Stankevich, E. Booth, J. Li, S. Chen, Z. Desai, J. Lowy, I. Fury, M.G. Migden, M.R. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz451.006 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz451_006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz451_006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1336-3cc30824fc8c5688488223315752bf9e6c01f5734fc9f53c56dccd6d08494ab53</originalsourceid><addsrcrecordid>eNotkE1OwzAQRrMAiVI4ALtZtlLT2nGSJsvK_LRSUSslrCN3YqtGiR3iFFRW3IHDcB9OQqqymplPT580z_PuKJlSkrKZMMYanNXlZxjRKSHxhTcgacD8ecTCK-_auVfSp2mQDryfVd0I7MAq2LbatrDWRrrTmR1dJ2uNkO9lK5ojjLZZPgZroNtLeFBKo8AjbBTwHmsqXYvdBAQsD7Uw8GyNxcoaUcHCdPr363t779MJaANb0WlpOtcX5tkYPnS3h0X5LgzKEvihE0bag4Ps7SDq08JlVQEXLWpjawEjnnE-vvEulaicvP2fQ-_l8SHnS3-9eVrxxdpHyljsM0RGkiBUmGAUJ0mYJEHAGI3mUbBTqYyRUBXNWQ-kKmI9UyKWcUmSMA3FLmJDj557sbXOtVIVTdt_2h4LSoqT7eJsuzjbLnqv7A8gLnfJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rischin, D. ; Khushalani, N.I. ; Schmults, C.D. ; Guminski, A. ; Chang, A.L.S. ; Lewis, K.D. ; Lim, A.M. ; Hernandez-Aya, L. ; Hughes, B.G.M. ; Schadendorf, D. ; Hauschild, A. ; Stankevich, E. ; Booth, J. ; Li, S. ; Chen, Z. ; Desai, J. ; Lowy, I. ; Fury, M.G. ; Migden, M.R.</creator><creatorcontrib>Rischin, D. ; Khushalani, N.I. ; Schmults, C.D. ; Guminski, A. ; Chang, A.L.S. ; Lewis, K.D. ; Lim, A.M. ; Hernandez-Aya, L. ; Hughes, B.G.M. ; Schadendorf, D. ; Hauschild, A. ; Stankevich, E. ; Booth, J. ; Li, S. ; Chen, Z. ; Desai, J. ; Lowy, I. ; Fury, M.G. ; Migden, M.R.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz451.006</identifier><language>eng</language><ispartof>Annals of oncology, 2019-12, Vol.30, p.xi35-xi36</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1336-3cc30824fc8c5688488223315752bf9e6c01f5734fc9f53c56dccd6d08494ab53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Rischin, D.</creatorcontrib><creatorcontrib>Khushalani, N.I.</creatorcontrib><creatorcontrib>Schmults, C.D.</creatorcontrib><creatorcontrib>Guminski, A.</creatorcontrib><creatorcontrib>Chang, A.L.S.</creatorcontrib><creatorcontrib>Lewis, K.D.</creatorcontrib><creatorcontrib>Lim, A.M.</creatorcontrib><creatorcontrib>Hernandez-Aya, L.</creatorcontrib><creatorcontrib>Hughes, B.G.M.</creatorcontrib><creatorcontrib>Schadendorf, D.</creatorcontrib><creatorcontrib>Hauschild, A.</creatorcontrib><creatorcontrib>Stankevich, E.</creatorcontrib><creatorcontrib>Booth, J.</creatorcontrib><creatorcontrib>Li, S.</creatorcontrib><creatorcontrib>Chen, Z.</creatorcontrib><creatorcontrib>Desai, J.</creatorcontrib><creatorcontrib>Lowy, I.</creatorcontrib><creatorcontrib>Fury, M.G.</creatorcontrib><creatorcontrib>Migden, M.R.</creatorcontrib><title>Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotkE1OwzAQRrMAiVI4ALtZtlLT2nGSJsvK_LRSUSslrCN3YqtGiR3iFFRW3IHDcB9OQqqymplPT580z_PuKJlSkrKZMMYanNXlZxjRKSHxhTcgacD8ecTCK-_auVfSp2mQDryfVd0I7MAq2LbatrDWRrrTmR1dJ2uNkO9lK5ojjLZZPgZroNtLeFBKo8AjbBTwHmsqXYvdBAQsD7Uw8GyNxcoaUcHCdPr363t779MJaANb0WlpOtcX5tkYPnS3h0X5LgzKEvihE0bag4Ps7SDq08JlVQEXLWpjawEjnnE-vvEulaicvP2fQ-_l8SHnS3-9eVrxxdpHyljsM0RGkiBUmGAUJ0mYJEHAGI3mUbBTqYyRUBXNWQ-kKmI9UyKWcUmSMA3FLmJDj557sbXOtVIVTdt_2h4LSoqT7eJsuzjbLnqv7A8gLnfJ</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Rischin, D.</creator><creator>Khushalani, N.I.</creator><creator>Schmults, C.D.</creator><creator>Guminski, A.</creator><creator>Chang, A.L.S.</creator><creator>Lewis, K.D.</creator><creator>Lim, A.M.</creator><creator>Hernandez-Aya, L.</creator><creator>Hughes, B.G.M.</creator><creator>Schadendorf, D.</creator><creator>Hauschild, A.</creator><creator>Stankevich, E.</creator><creator>Booth, J.</creator><creator>Li, S.</creator><creator>Chen, Z.</creator><creator>Desai, J.</creator><creator>Lowy, I.</creator><creator>Fury, M.G.</creator><creator>Migden, M.R.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201912</creationdate><title>Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)</title><author>Rischin, D. ; Khushalani, N.I. ; Schmults, C.D. ; Guminski, A. ; Chang, A.L.S. ; Lewis, K.D. ; Lim, A.M. ; Hernandez-Aya, L. ; Hughes, B.G.M. ; Schadendorf, D. ; Hauschild, A. ; Stankevich, E. ; Booth, J. ; Li, S. ; Chen, Z. ; Desai, J. ; Lowy, I. ; Fury, M.G. ; Migden, M.R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1336-3cc30824fc8c5688488223315752bf9e6c01f5734fc9f53c56dccd6d08494ab53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rischin, D.</creatorcontrib><creatorcontrib>Khushalani, N.I.</creatorcontrib><creatorcontrib>Schmults, C.D.</creatorcontrib><creatorcontrib>Guminski, A.</creatorcontrib><creatorcontrib>Chang, A.L.S.</creatorcontrib><creatorcontrib>Lewis, K.D.</creatorcontrib><creatorcontrib>Lim, A.M.</creatorcontrib><creatorcontrib>Hernandez-Aya, L.</creatorcontrib><creatorcontrib>Hughes, B.G.M.</creatorcontrib><creatorcontrib>Schadendorf, D.</creatorcontrib><creatorcontrib>Hauschild, A.</creatorcontrib><creatorcontrib>Stankevich, E.</creatorcontrib><creatorcontrib>Booth, J.</creatorcontrib><creatorcontrib>Li, S.</creatorcontrib><creatorcontrib>Chen, Z.</creatorcontrib><creatorcontrib>Desai, J.</creatorcontrib><creatorcontrib>Lowy, I.</creatorcontrib><creatorcontrib>Fury, M.G.</creatorcontrib><creatorcontrib>Migden, M.R.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rischin, D.</au><au>Khushalani, N.I.</au><au>Schmults, C.D.</au><au>Guminski, A.</au><au>Chang, A.L.S.</au><au>Lewis, K.D.</au><au>Lim, A.M.</au><au>Hernandez-Aya, L.</au><au>Hughes, B.G.M.</au><au>Schadendorf, D.</au><au>Hauschild, A.</au><au>Stankevich, E.</au><au>Booth, J.</au><au>Li, S.</au><au>Chen, Z.</au><au>Desai, J.</au><au>Lowy, I.</au><au>Fury, M.G.</au><au>Migden, M.R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)</atitle><jtitle>Annals of oncology</jtitle><date>2019-12</date><risdate>2019</risdate><volume>30</volume><spage>xi35</spage><epage>xi36</epage><pages>xi35-xi36</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz451.006</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-12, Vol.30, p.xi35-xi36 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz451_006 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T08%3A43%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Prior%20Lines%20of%20Systemic%20Therapy%20(PST)%20on%20the%20Efficacy%20Of%20Cemiplimab,%20a%20Human%20Monoclonal%20Anti%E2%80%93PD-1,%20in%20Patients%20(PTS)%20with%20Advanced%20Cutaneous%20Squamous%20Cell%20Carcinoma%20(CSCC)&rft.jtitle=Annals%20of%20oncology&rft.au=Rischin,%20D.&rft.date=2019-12&rft.volume=30&rft.spage=xi35&rft.epage=xi36&rft.pages=xi35-xi36&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz451.006&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz451_006%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |